[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

TW325406B - Percutaneous absorption preparation - Google Patents

Percutaneous absorption preparation

Info

Publication number
TW325406B
TW325406B TW084104420A TW84104420A TW325406B TW 325406 B TW325406 B TW 325406B TW 084104420 A TW084104420 A TW 084104420A TW 84104420 A TW84104420 A TW 84104420A TW 325406 B TW325406 B TW 325406B
Authority
TW
Taiwan
Prior art keywords
weight
percutaneous absorption
penetration enhancer
absorption preparation
monoglyceride
Prior art date
Application number
TW084104420A
Other languages
English (en)
Inventor
Shoichi Tokuta
Kazuhisa Futamiya
Yasuhiro Fukushima
Shigeyuki Watanabe
Mitsuru Ochiai
Original Assignee
Nikken Chemicals Co Ltd
Nitto Denko Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nikken Chemicals Co Ltd, Nitto Denko Corp filed Critical Nikken Chemicals Co Ltd
Application granted granted Critical
Publication of TW325406B publication Critical patent/TW325406B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW084104420A 1994-05-06 1995-05-03 Percutaneous absorption preparation TW325406B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6094241A JP2819236B2 (ja) 1994-05-06 1994-05-06 経皮吸収製剤

Publications (1)

Publication Number Publication Date
TW325406B true TW325406B (en) 1998-01-21

Family

ID=14104817

Family Applications (1)

Application Number Title Priority Date Filing Date
TW084104420A TW325406B (en) 1994-05-06 1995-05-03 Percutaneous absorption preparation

Country Status (10)

Country Link
US (1) US5618555A (zh)
EP (1) EP0680754B1 (zh)
JP (1) JP2819236B2 (zh)
KR (1) KR950031058A (zh)
CN (1) CN1116525A (zh)
AT (1) ATE171619T1 (zh)
CA (1) CA2147918A1 (zh)
DE (1) DE69505041T2 (zh)
ES (1) ES2123177T3 (zh)
TW (1) TW325406B (zh)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3576608B2 (ja) * 1994-11-15 2004-10-13 日東電工株式会社 貼付剤および貼付製剤
JPH1036265A (ja) * 1996-07-19 1998-02-10 Nitto Denko Corp ブプレノルフィン経皮吸収製剤
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US7150881B2 (en) 1997-06-26 2006-12-19 Mylan Technologies, Inc. Adhesive mixture for transdermal delivery of highly plasticizing drugs
US7220737B1 (en) 1997-09-04 2007-05-22 Novoneuron, Inc Noribogaine in the treatment of pain and drug addiction
DE69823520T2 (de) * 1997-09-04 2005-05-12 Novoneuron, Inc., Miami Noribogain zur behandlung von schmerzen und drogenabhängigkeit
JP4659943B2 (ja) 2000-02-25 2011-03-30 帝三製薬株式会社 塩酸ブプレノルフィン含有貼付剤
AU2001262683A1 (en) * 2000-06-02 2001-12-17 Teijin Limited Buprenorphine-containing patch
KR100448469B1 (ko) * 2001-10-26 2004-09-13 신풍제약주식회사 항염증제의 경피 조성물 및 장치
US7736665B2 (en) * 2002-05-31 2010-06-15 Titan Pharmaceuticals, Inc. Implantable polymeric device for sustained release of buprenorphine
EP1513532B1 (en) * 2002-06-10 2007-02-28 Euro-Celtique S.A. Disposal systems of transdermal delivery devices to prevent misuse of the active agents contained therein
KR101152183B1 (ko) * 2003-03-31 2012-06-15 타이탄 파머슈티컬즈 인코퍼레이티드 도파민 아고니스트의 지속 방출을 위한 이식가능한 폴리머디바이스
ATE375149T1 (de) * 2003-07-25 2007-10-15 Euro Celtique Sa Behandlung von entzug
WO2006085521A1 (ja) * 2005-02-10 2006-08-17 Nihon University オピオイドレセプター拮抗剤を含有する経皮吸収用医薬組成物およびその製造方法、並びに前記拮抗剤の経皮吸収促進方法
US20090274747A1 (en) * 2005-02-28 2009-11-05 Takashi Yasukochi Pressure-Sensitive Adhesive Base and Medical Adhesive Patch Including the Pressure-Sensitive Adhesive Base
CN102099015B (zh) * 2008-07-18 2015-05-06 拜奥莫达概念公司 释放活性成分的制品
TWI541246B (zh) * 2008-12-08 2016-07-11 歐陸斯迪公司 二氫羥戊甲嗎啡
US9394294B2 (en) 2010-05-11 2016-07-19 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US8765737B1 (en) 2010-05-11 2014-07-01 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US8362007B1 (en) 2010-05-11 2013-01-29 Demerx, Inc. Substituted noribogaine
US8741891B1 (en) 2010-06-22 2014-06-03 Demerx, Inc. N-substituted noribogaine prodrugs
US9586954B2 (en) 2010-06-22 2017-03-07 Demerx, Inc. N-substituted noribogaine prodrugs
US8802832B2 (en) 2010-06-22 2014-08-12 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US8637648B1 (en) 2010-06-22 2014-01-28 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
WO2012012764A1 (en) 2010-07-23 2012-01-26 Demerx, Inc. Noribogaine compositions
EP2481740B1 (en) 2011-01-26 2015-11-04 DemeRx, Inc. Methods and compositions for preparing noribogaine from voacangine
US9617274B1 (en) 2011-08-26 2017-04-11 Demerx, Inc. Synthetic noribogaine
WO2013085922A1 (en) 2011-12-09 2013-06-13 Demerx, Inc. Phosphate esters of noribogaine
EP2807168A4 (en) 2012-01-25 2015-10-14 Demerx Inc SYNTHETIC VOACANGINE
US9150584B2 (en) 2012-01-25 2015-10-06 Demerx, Inc. Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
EP2934541A4 (en) 2012-12-20 2016-08-03 Demerx Inc NORIBOGAINE SUBSTITUTE
US8940728B2 (en) 2012-12-20 2015-01-27 Demerx, Inc. Substituted noribogaine
US9045481B2 (en) 2012-12-20 2015-06-02 Demerx, Inc. Substituted noribogaine
GB201309654D0 (en) 2013-05-30 2013-07-17 Euro Celtique Sa Method
US9550789B2 (en) 2014-06-18 2017-01-24 Demerx, Inc. Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them
JP6695571B2 (ja) * 2016-12-05 2020-05-20 王子ホールディングス株式会社 経皮吸収型製剤
CN109487582A (zh) * 2018-11-19 2019-03-19 长沙浩然医疗科技有限公司 一种纯棉织物面料印染工艺
CN110013602B (zh) * 2019-04-17 2021-10-26 杨高云 用于治疗肢端型白癜风的手套及其制备方法
JP2023536152A (ja) 2020-07-30 2023-08-23 メレディアン・インコーポレーテッド 消費財包装用バイオベース材料
US11584110B2 (en) 2020-07-30 2023-02-21 Pepsico, Inc. Multi-layered packaging films

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
US4806341A (en) * 1985-02-25 1989-02-21 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
CH672888A5 (zh) * 1986-11-07 1990-01-15 Mepha Ag
ATE109357T1 (de) * 1988-02-26 1994-08-15 Riker Laboratories Inc Transdermales estradiol als therapeutisches sytem.
WO1991014463A1 (en) * 1990-03-28 1991-10-03 Noven Pharmaceuticals, Inc. Method and device for the release of drugs to the skin
US5026556A (en) * 1988-11-10 1991-06-25 Norwich Eaton Pharmaceuticals, Inc. Compositions for the transdermal delivery of pharmaceutical actives
EP0413034B1 (en) * 1989-02-28 1993-09-29 Teijin Limited Poultice and preparation thereof
US5240711A (en) * 1989-11-29 1993-08-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system comprising as active component buprenorphine
US5069909A (en) * 1990-06-20 1991-12-03 Cygnus Therapeutic Systems Transdermal administration of buprenorphine
US5149538A (en) * 1991-06-14 1992-09-22 Warner-Lambert Company Misuse-resistive transdermal opioid dosage form
US5238933A (en) * 1991-10-28 1993-08-24 Sri International Skin permeation enhancer compositions

Also Published As

Publication number Publication date
ATE171619T1 (de) 1998-10-15
JP2819236B2 (ja) 1998-10-30
KR950031058A (ko) 1995-12-18
EP0680754B1 (en) 1998-09-30
US5618555A (en) 1997-04-08
CN1116525A (zh) 1996-02-14
EP0680754A3 (en) 1996-03-06
DE69505041T2 (de) 1999-02-18
EP0680754A2 (en) 1995-11-08
ES2123177T3 (es) 1999-01-01
CA2147918A1 (en) 1995-11-07
JPH07304672A (ja) 1995-11-21
DE69505041D1 (de) 1998-11-05

Similar Documents

Publication Publication Date Title
TW325406B (en) Percutaneous absorption preparation
EP0393727A3 (en) Transdermal delivery system
AU576724B2 (en) Transdermally delivering nitroglycerine
CA2179040A1 (en) Percutaneously administrable patch preparation
AU1760988A (en) Enhancers for the transdermal flux of certain 1,4-dihydropyridine derivatives
AU3428393A (en) Use of polyamines as ionic-channel regulating agents
AU7554087A (en) Pharmaceutical composition with analgesic activity
NO941593D0 (zh)
CA2146723A1 (en) Percutaneous absorption preparation
AU1819288A (en) Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
IL106512A (en) Plaster for the transdermal application of steroid hormones and process for the preparation thereof
EP0664119A3 (en) Tape transdermal use easily detachable from the skin
AU3772989A (en) Penetration enhancers for transdermal delivery of systemic agent
WO1998036740A3 (de) Transdermales oder topisches pflastersystem mit polyacrylatmatrix mit verbesserten physikalischen eigenschaften
JPS6438300A (en) Preparation of decorative board on which pressed flower, etc. are applied
EP0379933A3 (de) Superfizielles therapeutisches System mit einem Gehalt an einem antineoplastischen Wirkstoff, insbesondere 5-Fluoruracil
EP0367489A3 (en) Thromboresistant materials and methods for making same
AU3712789A (en) 19-substituted progesterone derivatives useful as 19-hydroxylase inhibitors
AU1205792A (en) Percutaneous administration and absorption promoter composition and external preparation for percutaneous administration
EP0577699A4 (en) COMPOSITIONS AND METHODS INHIBITING ACTIVATION OF THE ACTIVE FACTOR XIII.
EP0267293A4 (en) PRE-TREATMENT ACTIVE INGREDIENT FOR PERCUTANEOUS ADMINISTRATION.
AU1761088A (en) Transdermal delivery of pharmaceuticals
TW218011B (zh)
AU7717587A (en) Nicorandil percutaneous absorption composition
NZ281334A (en) Transdermal patch comprising isosorbide dinitrate in a mixture of two different adhesives